Loss of Per2 in the TME leads to transcriptional rewiring at early stages of metastases formation, and suppresses subsequent metastatic tumor progression, highlighting Per2 as an unexpected protumorigenic mediator in the TME. Here, PER2 is linked to neoplasm.